Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • A team of researchers from the National Centre for Biological Sciences (NCBS), Bangalore, has succeeded in sequencing the genome of Tulsi, a step which will help identify the genes responsible for production of compounds with potential medicinal benefits. The team which included researchers from NCBS, inStem and CCAMP (Centre for Cellular and Molecular Platforms), all members of the Bangalore Life Sciences Cluster, used five different types of Tulsi, (Ocimum tenuflorium subtype Rama, O. tenuflorium subtype Krishna, O. gratissimum, O. saccharicum and O. kilmund) to collect the genomic data.

  • Sun Pharmaceutical Industries announced that Ranbaxy Pharmaceuticals Inc. (Ranbaxy), a wholly-owned subsidiary, along with its partners, Cipher Pharmaceuticals Inc. (Cipher) and Galephar Pharmaceutical Research, Inc. (Galephar) have entered into a settlement agreement with Actavis Group (Actavis) that dismisses the patent litigation suit relating to Actavis’ Abbreviated New Drug Application (ANDA) for a generic version of Absorica (isotretinoin capsules). Absorica is the registered trademark of Ranbaxy Laboratories Inc.

  • Researchers have developed a new smartphone app that help food inspectors inconspicuously collect data related to food safety observations in restaurants and supermarkets without any fuss. The study was published in the journal Food Protection Trends.

  • Previous research has suggested that exposure to heavy metal toxicants can influence a person's global DNA methylation profile. A new study has revealed that mothers with high levels of lead in their blood not only affect the fetal cells of their unborn children, but also their grandchildren. The study appeared online in the Scientific Reports.

  • Impax Laboratories, Inc., a specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved its generic version of glyburide tablets 1.25 mg, 2.5 mg, and 5 mg. The company is preparing for commercialisation of this product through Impax's generic division.

  • Nestle India on asked the apex consumer court why fresh tests were being ordered on Maggi noodles on food safety when a similar exercise has already been conducted as per directions of the Bombay High Court.

  • In a bid to ensure that children left out of routine immunization drive get vaccinated, the union health ministry launched the second part of Mission Indradhanush, its flagship vaccination programme.

  • Researchers have designed and synthesised a nanometer-scale DNA "machine" that can make the process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV much cheaper.

Subscribe to Pharma News